サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1529869

子宮内避妊用具（IUD）の市場規模、シェア、動向分析レポート：タイプ別、流通チャネル別、地域別、セグメント予測、2024年～2030年

Intrauterine Devices Market Size, Share & Trends Analysis Report By Type (Hormonal IUD, Copper IUD), By Distribution Channel (Hospital, Gynecology Clinics), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
子宮内避妊用具（IUD）の市場規模、シェア、動向分析レポート：タイプ別、流通チャネル別、地域別、セグメント予測、2024年～2030年
出版日: 2024年07月26日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

子宮内避妊用具（IUD）市場の成長と動向：

Grand View Research社の最新レポートによると、子宮内避妊用具（IUD）の世界市場は2030年までに80億2,000万米ドルに達すると予測され、2024年から2030年までのCAGRは3.66％で成長すると予測されています。

家族計画やリプロダクティブ・ヘルス（性と生殖に関する健康）に対する意識が高まり、避妊具の使用率が世界的に高まっています。意図しない妊娠の減少を目指す政府の取り組みも、子宮内避妊用具（IUD）などの効果的な避妊法の採用に寄与しています。様々なホルモン性・非ホルモン性オプションのイントロダクションを含むIUDデザインの技術的進歩は、多様な消費者の嗜好に対応し、使用感を向上させています。さらに、日常的な介入なしに利便性と有効性を提供する長時間作用型可逆的避妊薬（LARC）への動向が、特に若年層の間で高まっています。

避妊薬に対する政府支出は急速に伸びており、これが予測期間中の市場成長の原動力になると予想されます。家族計画2030」報告書によると、2022年の二国間家族計画に対する政府からの資金提供は、米国が5億8,290万米ドル（43％）、次いでオランダ2億1,740万米ドル（16％）、英国1億7,470万米ドル（13％）、スウェーデン1億2,130万米ドル（9％）、カナダ8,830万米ドル（7％）となっています。

市場は大手企業で高度に統合されているため、各社は研究開発への多額の投資に注力するとともに、M&Aや製品パイプラインの拡大などさまざまな戦略を採用しています。例えば、Medicines360は2022年11月、最長8年間の妊娠を予防するホルモンIUD「リレッタ」のFDA承認を取得しました。この承認は、米国で1,751人の女性が参加し、リレッタ52mgを使用した第3相臨床試験の有効性と安全性のデータを追加評価した後に認められました。

子宮内避妊用具（IUD）市場レポートハイライト：

  • タイプ別では、ホルモンIUD分野が2023年に72.99%の最大売上シェアで市場をリードしました。これは、高い妊娠予防効果、月経出血の減少、症状管理の改善、医療従事者が二重の利点からホルモン性IUDを推奨し、技術的進歩が消費者を惹きつけていることによる認知度の上昇に起因します。
  • 販売チャネル別では、病院セグメントが2023年に54.44%の最大売上シェアで市場をリードしました。これは、長期にわたる高い利益、病院での包括的な家族計画サービス、ヘルスケア統合の強化、保険適用範囲の拡大、専門スタッフがこのセグメントの需要と成長を後押ししているためです。
  • アジア太平洋地域は2023年に32.08%の最大売上シェアで市場を独占したが、これはIUDの受容率の上昇、政府の支援政策、女性ヘルスケアへの注目の高まり、長時間作用型可逆的避妊薬への嗜好の高まりに起因します。
  • 2022年10月、バイエル社は欧州においてレボノルゲストレル（LNG）放出型IUD「ミレーナ」の使用期間を最長8年に延長しました。この承認はミレーナ延長試験に基づくもので、6年目から8年目まで99％以上の避妊効果が確認されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場脅威分析
  • ビジネス環境分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 タイプ別、ビジネス分析

  • タイプ別市場シェア、2023年と2030年
  • タイプ別セグメントダッシュボード
  • 市場規模と予測および動向分析、タイプ別、2018～2030年
  • ホルモン性IUD
    • ホルモン性IUD市場、2018-2030年
  • 銅製IUD
    • 銅製IUD市場、2018-2030年

第5章 流通チャネル別、ビジネス分析

  • 流通チャネル別市場シェア、2023年および2030年
  • 流通チャネル別セグメントダッシュボード
  • 市場規模と予測および動向分析、流通チャネル別、2018～2030年
  • 病院
    • 病院市場、2018年-2030年
  • 婦人科クリニック
    • 婦人科クリニック市場、2018年-2030年
  • コミュニティヘルスケアセンター
    • コミュニティヘルスケアセンター市場、2018年-2030年
  • その他
    • その他市場、2018年-2030年

第6章 地域別、推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 市場規模と予測動向分析、2018年から2030年
  • 北米
    • 北米のIUD市場推計・予測、2018-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州のIUD市場推計・予測、2018-2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋地域のIUD市場推計・予測、2018-2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカのIUD市場推計・予測、2018-2030
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ IUD市場推計・予測、2018年-2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参入企業概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/リスト
    • AbbVie Inc.
    • CooperSurgical Inc.
    • Bayer AG
    • EUROGINE, SL
    • Pregna International Limited.
    • Mona Lisa NV
    • Prosan International BV
    • SMB Corporation of India
    • OCON Medical Ltd.
    • DKT International
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global IUD market, by type, 2018 - 2030 (USD Million)
  • Table 4. Global IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 5. Global IUD market, by region, 2018 - 2030 (USD Million)
  • Table 6. North America IUD market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America IUD market, by type, 2018 - 2030 (USD Million)
  • Table 8. North America IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9. U.S. IUD market, by type, 2018 - 2030 (USD Million)
  • Table 10. U.S. IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11. Canada IUD market, by type, 2018 - 2030 (USD Million)
  • Table 12. Canada IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13. Mexico IUD market, by type, 2018 - 2030 (USD Million)
  • Table 14. Mexico IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15. Europe IUD market, by country, 2018 - 2030 (USD Million)
  • Table 16. Europe IUD market, by type, 2018 - 2030 (USD Million)
  • Table 17. Europe IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18. UK IUD market, by type, 2018 - 2030 (USD Million)
  • Table 19. UK IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20. Germany IUD market, by type, 2018 - 2030 (USD Million)
  • Table 21. Germany IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22. France IUD market, by type, 2018 - 2030 (USD Million)
  • Table 23. France IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24. Italy IUD market, by type, 2018 - 2030 (USD Million)
  • Table 25. Italy IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26. Spain IUD market, by type, 2018 - 2030 (USD Million)
  • Table 27. Spain IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28. Norway IUD market, by type, 2018 - 2030 (USD Million)
  • Table 29. Norway IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30. Sweden IUD market, by type, 2018 - 2030 (USD Million)
  • Table 31. Sweden IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32. Denmark IUD market, by type, 2018 - 2030 (USD Million)
  • Table 33. Denmark IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific IUD market, by country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific IUD market, by type, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37. Japan IUD market, by type, 2018 - 2030 (USD Million)
  • Table 38. Japan IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39. China IUD market, by type, 2018 - 2030 (USD Million)
  • Table 40. China IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41. India IUD market, by type, 2018 - 2030 (USD Million)
  • Table 42. India IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43. Australia IUD market, by type, 2018 - 2030 (USD Million)
  • Table 44. Australia IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45. South Korea IUD market, by type, 2018 - 2030 (USD Million)
  • Table 46. South Korea IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47. Thailand IUD market, by type, 2018 - 2030 (USD Million)
  • Table 48. Thailand IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49. Latin America IUD market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America IUD market, by type, 2018 - 2030 (USD Million)
  • Table 51. Latin America IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52. Brazil IUD market, by type, 2018 - 2030 (USD Million)
  • Table 53. Brazil IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54. Argentina IUD market, by type, 2018 - 2030 (USD Million)
  • Table 55. Argentina IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa IUD market, by country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa IUD market, by type, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59. South Africa IUD market, by type, 2018 - 2030 (USD Million)
  • Table 60. South Africa IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia IUD market, by type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63. UAE IUD market, by type, 2018 - 2030 (USD Million)
  • Table 64. UAE IUD market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65. Kuwait IUD market, by type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait IUD market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 IUD market : Type outlook and key takeaways
  • Fig. 17 IUD market : Type movement analysis
  • Fig. 18 Hormonal IUD market, 2018 - 2030 (USD Million)
  • Fig. 19 Copper IUD market, 2018 - 2030 (USD Million)
  • Fig. 20 IUD market : Distribution channel outlook and key takeaways
  • Fig. 21 IUD market : Distribution channel movement analysis
  • Fig. 22 Hospital market, 2018 - 2030 (USD Million)
  • Fig. 23 Gynecology clinics market, 2018 - 2030 (USD Million)
  • Fig. 24 Community health care centers market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 Regional outlook, 2023 & 2030
  • Fig. 28 IUD market : Region movement analysis
  • Fig. 29 North America IUD market , 2018 - 2030 (USD Million)
  • Fig. 30 US IUD market, 2018 - 2030 (USD Million)
  • Fig. 31 Key country dynamics
  • Fig. 32 Canada IUD market, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 Mexico IUD market, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Europe IUD market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany IUD market, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 UK IUD market, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 France IUD market, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Italy IUD market, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain IUD market, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Sweden IUD market, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Norway IUD market, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark IUD market, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Asia Pacific IUD market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan IUD market, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 China IUD market, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 India IUD market, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Australia IUD market, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 South Korea IUD market, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Thailand IUD market, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Latin America IUD market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil IUD market, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Argentina IUD market, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Middle East and Africa IUD market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa IUD market, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Saudi Arabia IUD market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 UAE IUD market, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Kuwait IUD market, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Company categorization
  • Fig. 81 Strategy mapping
  • Fig. 82 Company market position analysis
目次
Product Code: GVR-4-68040-383-5

Intrauterine Devices Market Growth & Trends:

The global intrauterine devices market is anticipated to reach USD 8.02 billion by 2030 and is projected to grow at a CAGR of 3.66% from 2024 to 2030, according to a new report by Grand View Research, Inc. There is a growing awareness of family planning and reproductive health, leading to higher rates of contraceptive usage globally. Government initiatives aiming to reduce unintended pregnancies have also contributed to the adoption of effective contraceptive methods, such as intrauterine devices (IUD). Technological advancements in IUD design, including the introduction of various hormonal and non-hormonal options, cater to diverse consumer preferences and improve user experience. Moreover, the trend towards long-acting reversible contraceptives (LARCs), which provide convenience and effectiveness without daily intervention, is gaining traction, particularly among younger demographics.

The government spending on contraceptives is growing rapidly, and this is expected to drive market growth over the forecast period. According to the Family Planning 2030 report, the U.S. accounted for USD 582.9 million (43%), followed by the Netherlands USD 217.4 million (16%), UK USD 174.7 million (13%), Sweden USD 121.3 million (9%) and Canada USD 88.3 million (7%) funding from the government for bilateral family planning in 2022.

Due to the highly consolidated market with major players, companies are focusing on significant investments in research and development, as well as adopting various strategies such as mergers and acquisitions and expanding their product pipelines. For instance, in November 2022, Medicines360 obtained FDA approval for the Liletta hormonal IUD for preventing pregnancy for up to 8 years. The approval was granted after evaluating additional efficacy and safety data from a phase 3 clinical trial involving 1,751 women in the U.S. and using Liletta 52 mg.

Intrauterine Devices Market Report Highlights:

  • Based on type, the hormonal IUDs segment led the market with the largest revenue share of 72.99% in 2023. This is attributed to the high pregnancy prevention efficacy, reduced menstrual bleeding, improved symptom management, and rising awareness, with healthcare providers recommending hormonal IUDs for their dual benefits and technological advancements attracting consumers
  • Based on distribution channel, the hospital segment led the market with the largest revenue share of 54.44% in 2023. This is attributed to the high long-term benefits, comprehensive hospital family planning services, enhanced healthcare integration, expanding insurance coverage, and specialized staff boost demand and growth in this segment
  • Asia Pacific dominated the market with the largest revenue share of 32.08% in 2023, which is attributed to rising acceptance of IUDs, supportive government policies, increased focus on women's healthcare, and a growing preference for long-acting reversible contraception
  • In October 2022, Bayer AG extended the usage duration of its levonorgestrel (LNG) releasing IUD Mirena to up to eight years in Europe. This approval, based on the Mirena Extension Trial, confirms over 99% contraceptive efficacy from year six to eight

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Government and NGO initiatives to promote IUD methods
      • 3.2.1.2. Increasing prevalence of unwanted pregnancies
      • 3.2.1.3. Rising number of women with unmet contraception needs
      • 3.2.1.4. Technological advancement leading to effective contraception and less side effects
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Rising prevalence of infertility
      • 3.2.2.2. Adverse effects associated with the use of IUDs
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Threat Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Type Business Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Hormonal IUD
    • 4.4.1. Hormonal IUD market, 2018 - 2030 (USD Million)
  • 4.5. Copper IUD
    • 4.5.1. Copper IUD market, 2018 - 2030 (USD Million)

Chapter 5. Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2023 & 2030
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Hospital
    • 5.4.1. Hospital market, 2018 - 2030 (USD Million)
  • 5.5. Gynecology Clinics
    • 5.5.1. Gynecology Clinics market, 2018 - 2030 (USD Million)
  • 5.6. Community Health Care Centers
    • 5.6.1. Community Health Care Centers market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Regional Estimates & Trend Analysis by Type & Distribution Channel

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 6.4. North America
    • 6.4.1. North America IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamic
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive insights
      • 6.4.2.4. U.S. IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamic
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive insights
      • 6.4.3.4. Canada IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamic
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive insights
      • 6.4.4.4. Mexico IUD market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamic
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive insights
      • 6.5.2.4. Germany IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. UK
      • 6.5.3.1. Key country dynamic
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive insights
      • 6.5.3.4. UK IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key country dynamic
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive insights
      • 6.5.4.4. France IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key country dynamic
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive insights
      • 6.5.5.4. Italy IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key country dynamic
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive insights
      • 6.5.6.4. Spain IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key country dynamic
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive insights
      • 6.5.7.4. Denmark IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key country dynamic
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive insights
      • 6.5.8.4. Sweden IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key country dynamic
      • 6.5.9.2. Regulatory framework
      • 6.5.9.3. Competitive insights
      • 6.5.9.4. Norway IUD market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamic
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive insights
      • 6.6.2.4. Japan IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key country dynamic
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive insights
      • 6.6.3.4. China IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamic
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive insights
      • 6.6.4.4. India IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamic
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive insights
      • 6.6.5.4. South Korea IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key country dynamic
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive insights
      • 6.6.6.4. Australia IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key country dynamic
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive insights
      • 6.6.7.4. Thailand IUD market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America IUD market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamic
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive insights
      • 6.7.2.4. Brazil IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamic
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive insights
      • 6.7.3.4. Argentina IUD market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamic
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive insights
      • 6.8.2.4. South Africa IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamic
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive insights
      • 6.8.3.4. Saudi Arabia IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamic
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive insights
      • 6.8.4.4. UAE IUD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key country dynamic
      • 6.8.5.2. Regulatory framework
      • 6.8.5.3. Competitive insights
      • 6.8.5.4. Kuwait IUD market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. AbbVie Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. CooperSurgical Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Bayer AG
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. EUROGINE, S.L.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Pregna International Limited.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Mona Lisa N.V.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Prosan International BV
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. SMB Corporation of India
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. OCON Medical Ltd.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. DKT International
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product benchmarking
      • 7.5.10.4. Strategic initiatives